Trimethylamine N-oxide (TMAO)

Trimethylamine N-oxide (TMAO) is a compound your body produces after gut bacteria break down certain nutrients found in food. It circulates in the bloodstream and has been linked to inflammation, plaque buildup, and cardiovascular disease risk.

TMAO is not a household name yet, but it is gaining attention in preventive cardiology as a biomarker that connects gut health to heart health. Understanding it helps explain why two people can eat a similar diet and have very different cardiovascular outcomes.

TMAO is a metabolite, meaning it is a byproduct of metabolism. It is produced when gut bacteria process specific nutrients in food, primarily choline, L-carnitine, and betaine. After gut bacteria convert these nutrients into a compound called TMA, the liver oxidizes TMA into TMAO.

TMAO then enters the bloodstream and is eventually cleared by the kidneys.

Elevated blood levels of TMAO have been associated with a higher risk of heart attack, stroke, and cardiovascular mortality in multiple large studies. It is increasingly used as part of advanced cardiovascular risk assessment in preventive cardiology.

The pathway from food to TMAO involves three steps.

Step 1: Dietary nutrients. Foods rich in choline, L-carnitine, and betaine provide the raw material. These include red meat, egg yolks, dairy, and certain seafood.

Step 2: Gut bacteria convert nutrients into TMA. Specific species of bacteria in the gut break down these nutrients and produce trimethylamine (TMA). Not everyone has the same bacteria. Microbiome composition varies between individuals, which is why the same food can produce very different TMAO levels in different people.

Step 3: The liver converts TMA into TMAO. TMA travels from the gut to the liver through the portal vein. The liver uses an enzyme called FMO3 to oxidize TMA into TMAO. The amount of FMO3 activity varies between individuals and affects how much TMAO is produced.

The simplified pathway is: Diet → Gut Bacteria → TMA → Liver → TMAO → Bloodstream.

This three-step process explains why TMAO is as much about your gut bacteria as it is about what you eat.

Foods high in choline and L-carnitine tend to produce the most TMAO in people with the relevant gut bacteria.

High-producing foods include red meat such as beef and pork, egg yolks, processed and cured meats, full-fat dairy, and energy drinks or supplements containing L-carnitine.

The amount of TMAO produced is not the same for everyone. A person with a microbiome rich in TMA-producing bacteria will generate far more TMAO from a steak than someone whose microbiome lacks those species. This individual variability is central to understanding TMAO.

Dietary patterns matter more than single foods. A consistently high intake of red meat and processed foods feeds TMA-producing bacteria over time and raises average TMAO levels. Shifting toward a Mediterranean diet supports a microbiome that produces less TMAO.

The gut microbiome plays a central role in TMAO production and in cardiovascular inflammation more broadly.

A microbiome with diverse, balanced bacterial species tends to produce less TMA. A microbiome in a state of dysbiosis, where harmful bacteria dominate, produces more. Dysbiosis is associated with chronic low-grade inflammation throughout the body.

TMAO itself activates inflammatory signaling pathways. It promotes the production of cytokines, which are proteins that amplify inflammation inside artery walls. This creates a feedback loop where poor gut health drives both higher TMAO and higher inflammation.

The gut-heart connection, sometimes called the gut-heart axis, is an active area of cardiovascular research. It helps explain why inflammation biomarkers like hsCRP are elevated in people with both gut dysbiosis and high TMAO.

Supporting microbiome diversity through diet and lifestyle is one of the most practical ways to address TMAO at its source.

Dietary strategies. Reducing red meat and processed meat intake lowers the supply of choline and carnitine available for TMA production. Shifting toward a plant-forward diet rich in vegetables, legumes, whole grains, and fish reduces average TMAO levels in most people.

Improve gut microbiome diversity. Fiber feeds beneficial bacteria and reduces the dominance of TMA-producing species. Fermented foods like yogurt, kefir, and kimchi support microbial balance. Polyphenols found in berries, olive oil, green tea, and dark chocolate also promote a healthier microbiome.

Exercise. Regular aerobic exercise improves microbiome diversity and reduces systemic inflammation. It supports metabolic pathways that lower both TMA production and TMAO circulation.

Limit alcohol. Heavy alcohol use disrupts gut bacteria balance and promotes dysbiosis, which in turn raises TMA production.

Vegan and vegetarian diets tend to produce lower TMAO because they are low in L-carnitine. However, people who eat no animal products for a long time often have fewer TMA-producing bacteria regardless of carnitine intake. Microbiome adaptation plays an important role.

One nuance worth noting is the fish paradox. Fish contains preformed TMAO and raises blood TMAO levels after eating. Yet fish consumption is consistently associated with lower cardiovascular risk, not higher. The omega-3 fatty acids and other nutrients in fish appear to outweigh the TMAO contribution. This suggests that food context and overall dietary pattern matter more than TMAO from any single source.

TMAO Testing

TMAO can be measured through a fasting blood test. It is not part of a standard lipid panel but is available through specialized cardiovascular and functional medicine labs.

Interpreting TMAO results requires clinical context. High TMAO in a person with other cardiovascular risk factors is more meaningful than an isolated elevated result. It works best as part of a broader assessment that includes lipoprotein(a), LDL particle size, hsCRP, and other advanced markers.

Testing for TMAO is most useful in patients with intermediate cardiovascular risk where standard testing leaves uncertainty, and in people interested in personalized nutrition and microbiome-guided prevention strategies.

The Fish Paradox

Fish naturally contains TMAO, and eating fish raises blood TMAO levels temporarily. Yet decades of research consistently show that higher fish consumption is associated with lower cardiovascular mortality.

This apparent contradiction is explained by the full nutritional package that fish provides. Omega-3 fatty acids reduce inflammation, lower triglycerides, and improve endothelial function. These benefits appear to substantially outweigh any risk from fish-derived TMAO.

The fish paradox is a useful reminder that no single biomarker tells the whole story. Diet, microbiome, genetics, and overall lifestyle interact in ways that cannot be captured by one number.